Investigative Medicine Department - Welcome
Department of Investigative Medicine, Imperial College, London

Clinical Service for Patients: Multiple Endocrine Neoplasia (MEN) Syndrome

The Hammersmith Hospital is a tertiary referral centre for patients with multiple endocrine neoplasia.

Multiple Endocrine Neoplasia (MEN) is a group of disorders where affected individuals develop tumours in two or more endocrine glands at the same time, making the affected glands overactive. With several endocrine systems being overactive, a diverse range of symptoms is seen. They are inherited disorders (inherited in an autosomal dominant pattern).

There are two main types of MEN syndrome:

MEN type 1
This is a rare disorder, affecting approximately 0.25% of the population. It affects all age groups, with cases reported from 5-81 years of age. Clinical symptoms have normally appeared by the fifth decade of life.

It is characterised by the co-existence of:

MEN type 2
This syndrome is less common than MEN 1, but again affects all age groups with cases reported from 2-60 years of age. Symptoms develop less readily than in MEN 1 with 40% of people with the gene remaining asymptomatic at 70 years of age.

It is divided into two further sub-classes:

MEN 2a The most common variant of MEN 2. This is characterised by:

MEN2b This has no parathyroid involvement and is characterised by:

The syndrome can occur with the only manifestation being medullary thyroid carcinoma.

The Hammersmith Hospital has considerable expertise in managing patients with MEN-1 and MEN-2. Our multidicliplinary team of endocrinologists, radiologists, surgeons, radiothrapists and oncologists are able to provide such patients with the best clinical care.

Link to: http://www.endocrine-abstracts.org/ea/0003/ea0003p127.htm

About Hammersmith Hospital Endocrinology | Privacy & Accessibility Policy | Contact Us | Last Updated: January 25, 2008
©2006 Department of Investigative Medicine, Imperial College and Imperial College Healthcare NHS Trust